share_log

Beam Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Robert Nelsen(6.8%),ARCH Venture Fund IX, L.P.(6.7%), etc.

Beam Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Robert Nelsen(6.8%),ARCH Venture Fund IX, L.P.(6.7%)等

SEC announcement ·  02/14 15:24
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息